Turkish Version of Pelvi-Perineal Surgery Sexuality Questionnaire

This prospective, multicentre observational study translates the 13-item Pelvi-Perineal Surgery Sexuality Questionnaire (PPSSQ) from French to Turkish, culturally adapts it, and evaluates its reliability, validity and responsiveness in Turkish-speaking women covering from pelvic floor surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus

Age range

18 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

About this study

Sexual function is a key outcome after incontinence or prolapse surgery; however, no Turkish tool specifically captures surgery-related sexual issues. The Pelvi-Perineal Surgery Sexuality Questionnaire (PPSSQ) was recently validated in France and measures two dimensions ("Sexual Health" and "Discomfort & Pain") with good psychometric performance.

The English version of PPSSQ will be adapted for Turkish use according to the established guidelines for cross-cultural adaptation of self-reported questionnaires. The guideline has 5 steps: (1) translation, (2) synthesis, (3) back translation, (4) evaluation by a team of experts, and (5) pretests. 80 sexually active and inactive women (≥18 y) with mid-urethral sling, vaginal or laparoscopic prolapse repair (with/without mesh) will be recruited. Participants will complete the Turkish version of the Female Sexual Function Index (FSFI-Turkish) on the first visit and again 7 days later for validation purposes. Internal consistency will be tested using Cronbach's alpha, and the test-retest reliability will be assessed by calculating the intra-class correlation coefficient.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Having had pelvic surgery more than 12 months ago
Being sexually active for the last three months
Being literate

Exclusion criteria

Not having had a sexual partner for at least three months
Receiving anti-estrogen therapy for any reason
Having a history of gynecological or breast cancer
Not understanding written Turkish

Treatment and study plan

Survey using a questionnaire

Other

Eighty women, determined by the number of questions times the rule of 10, will be asked to fill out the Pelvi-Perineal Surgery Sexuality Questionnaire - PPSSQ and Female Sexual Function Index (FSFI) questionnaires and will be asked to fill out the PPSSQ again 7 days later for test-retest reliability.

Other names: Permission was obtained from the original owner of Pelvi-Perineal Surgery Sexuality Questionnaire - PPSSQ for the Turkish cultural adaptation, validity and reliability study.

Primary outcomes

Pelvi-Perineal Surgery Sexuality Questionnaire

Time frame: 1 week

The Pelvi-Perineal Surgery Sexuality Questionnaire (PPSSQ) is a 13-question self-questionnaire validated in a population of sexually active women or not, operated on for stress urinary incontinence or pelvic organ prolapse by laparoscopy or vaginal surgery, with or without mesh. The domains are "Sexual Health" and "Discomfort and Pain." The questionnaire is calculated out of 100 points, with a higher score indicating better sexual function.

Secondary outcomes

Female Sexual Function Index (FSFI)

Time frame: 1 week

It is a 19-item multidimensional self-reporting measure that quantified female sexual dysfunction in six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. These questions ask about patients' sexual feelings and responses during the past 4 weeks. FSFI use a 5-point Likert scale ranging from 1-5 with higher scores indicating greater levels of sexual functioning.

Sponsors and collaborators

Lead sponsor

Bezmialem Vakif University

Other

Registry information

Official study title

Turkish Version of Pelvi-Perineal Surgery Sexuality Questionnaire: Translation, Cultural Adaptation and Validation

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: Jul 29, 2025
Registry last updated: Jan 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.